GlassScriptPhysician profile
Pooja Shah
NPI 1558951731
$1,455.84
in general payments reported to CMS, 2019-2025
13 companies · $920 in 2025
The $920 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $45.36 · 2023: $92.53 · 2024: $398 · 2025: $920.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829 · Travel and Lodging: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.13 |
| Travel and Lodging | $581.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $858.94 | 2024-2025 | Iovera, Zilretta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.45 | 2025 | Relistor |
| Nalu Medical, INC. | $70.97 | 2024 | Nalu Neurostimulation System |
| Electronic Waveform Lab, INC. | $70.67 | 2023-2024 | |
| Collegium Pharmaceutical, INC. | $63.82 | 2023-2025 | Xtampza, Belbuca |
| Si-Bone, INC. | $60.97 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $28.72 | 2023 | Rexulti |
| Spinal Simplicity, LLC | $27.06 | 2024 | Ha Minuteman G3-R |
| Genzyme Corporation | $23.12 | 2021 | |
| Amgen INC. | $22.24 | 2021 | |
| Depuy Synthes Sales INC. | $19.12 | 2023 | Monovisc |
| Kowa Pharmaceuticals America, INC. | $15.57 | 2023 | Seglentis |
| Curonix LLC | $14.19 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.